Cyclosporine: a new immunosuppressive agent for organ transplantation.
about
Cyclosporin A for primary biliary cirrhosisCyclosporin A for primary biliary cirrhosisRepurposing drugs for the treatment and control of helminth infectionsLung and heart allocation in the United StatesInteraction of FKBP12-FK506 with calcineurin A at the B subunit-binding domainTopical tacrolimus and cyclosporin A differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin E hypersensitivityPolymyositis and cyclosporin ACyclosporin A inhibits smooth muscle proliferation in the vascular response to injury.Cyclosporin treatment does not impair the release of nitric oxide in human coronary arteries.Late complications after cardiac transplantationA Novel Derivative of (-)mycousnine Produced by the Endophytic Fungus Mycosphaerella nawae, Exhibits High and Selective Immunosuppressive Activity on T Cells.Naturally occurring circular proteins: distribution, biosynthesis and evolution.Peripartum cardiomyopathy--successful treatment with cardiac transplantation.An Analysis of the Causes of Death After Pediatric Liver Transplantation.Vascular effects of cyclosporine A in vivo and in vitro.Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: possible lack of relationship to immunosuppressive activity.The utility of cyclosporine weaning in renal transplantation.Onychomycosis in patients with nail psoriasis: a point to point discussion.Concentrations of ciclosporin in allogeneic bone marrow recipients. Comparison of assay methods.Effects of Dipeptidyl Peptidase-4 Inhibitors on Hyperglycemia and Blood Cyclosporine Levels in Renal Transplant Patients with Diabetes: A Pilot StudySurgical management of congenital heart defects: current trends.Renal transplantation in high-risk patients.Cyclosporin A inhibits the growth of Cryptococcus neoformans in a murine modelAntischistosomal effect of cyclosporin A: cure and prevention of mouse and rat schistosomiasis mansoniPD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation.Elevation of blood ciclosporin levels by voriconazole leading to leukoencephalopathyCalcineurin inhibitor minimization in pediatric liver allograft recipients.Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats.Angiotensin Type-2 (AT-2)-Receptor activation reduces renal fibrosis in cyclosporine nephropathy: Evidence for blood-pressure independent effect.The use of cyclosporin A in adult nephrotic syndrome: nine cases and literature review.Immunomodulating options for liver transplant patients.Effects of cyclosporine in spontaneous, posterior uveitis.The safety of calcineurin inhibitors for kidney-transplant patients.Cyclosporin in dermatologic disorders.Liver transplantation: an update for physicians.Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid- and Calcineurin Inhibitor-Free Future?Influence of cyclosporine A on glomerular growth and the effect of mizoribine and losartan on cyclosporine nephrotoxicity in young ratsRenal transplant immunology in the last 20 years: A revolution towards graft and patient survival improvement.Dynamic changes in chromatin conformation at the TNF transcription start site in T helper lymphocyte subsets.Acute and chronic graft-versus-host disease in man.
P2860
Q24243989-A7324A06-6A78-4163-B74E-7F5E2C96C30EQ24246095-E584D9C0-F039-4931-8C16-EFB579F10BC9Q26823355-6A20806B-5FFB-4F3B-A905-221BCF69DFC2Q27009484-5C7BDE3D-6E51-4C42-8EA6-FD75A9DB1295Q28288118-E67B649F-C4AA-4F10-9DE5-96614FC05BDBQ28362822-8F969BBF-EA2E-4204-A7BC-C4A072B38729Q33562319-0302553B-0051-4E38-84E1-57FE1A0CF482Q33564406-AE7D8CB6-AA56-4F89-ACB0-9FD1FFEB587AQ33611345-2AFC0605-1F26-4237-BEAF-EA2ED6B1423AQ33613810-0D2D806A-5AAF-4109-9FB9-BF7C887584C6Q33871002-85244704-5423-4834-88D0-2B549B298BDBQ34137547-BE6BB138-7A6B-407C-828A-C851842E8DFFQ34195232-BADFD683-848D-4685-8A6D-57706FB96E46Q34434458-F2E53CE3-8F2E-4FFC-9597-06D4D503F660Q35811806-8ADA0740-9BD8-4D4C-92F8-7F14C2DDBFC0Q35873547-43DB32AE-9133-4934-98ED-871B8F90D26CQ35975872-7FC4CBC9-73E9-44B1-9246-44CEAA9A9D6DQ36103852-6DB92284-9EE0-4ECA-85C4-7A956FCD7E90Q36447399-64D4B6C8-5B22-4D3C-9882-6BEFDE58EA68Q36717018-F0E180E6-FDFF-44EA-AFCB-49397878D22EQ36720807-976DFB94-5E34-4CA1-9812-77E78AAA0801Q36895544-7A85BCD1-6119-42A7-BFAE-5361099E7C47Q36992132-BA121D6C-4707-4D5B-9498-585CC26E1172Q37027552-2E9947DD-D177-4581-AC81-065F597B5F16Q37228818-B0CCDAE4-9A8B-4628-8518-F65359A72D1CQ37303616-7B4DC80A-FB43-4F40-BBD7-A3D360FBE8EAQ37469274-FC44459C-A5E3-4DC1-9F33-D6CC9A36553BQ37557942-988D70FD-E136-4CF9-B714-98BEAD382002Q37626862-E1367B9E-19CA-444B-B49D-C433D61C3051Q37979551-A5E6F46B-353B-4AA4-AFC8-B6B2DBBE1461Q38044761-61D2C416-1075-426F-AB3D-446928DCD753Q38477174-16BBE3E1-9CD7-4782-81A9-4766270F9AA0Q38578386-F345FF84-37C2-4EDE-9EAA-3636B8FB4F0FQ38689117-AFA0EB47-C75C-4F3D-B5FD-469FCD185FA9Q38693702-740E596E-11E6-4B3F-80ED-A548BF8241C1Q38804454-0C8AF22E-EBA1-4426-BCBB-2BED91380721Q38805449-CC8ED363-D722-437B-8C3E-3AE76DBC6E92Q38967258-1D85292F-DF5B-4EB8-B87B-64410AC38FBAQ39099558-BE771605-1033-4DB2-8C76-FAB8E9B183CBQ39479544-A2AE70DC-0E8E-4597-A27D-7CBE3871E65A
P2860
Cyclosporine: a new immunosuppressive agent for organ transplantation.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Cyclosporine: a new immunosuppressive agent for organ transplantation.
@en
type
label
Cyclosporine: a new immunosuppressive agent for organ transplantation.
@en
prefLabel
Cyclosporine: a new immunosuppressive agent for organ transplantation.
@en
P2093
P1476
Cyclosporine: a new immunosuppressive agent for organ transplantation.
@en
P2093
C B Carpenter
N L Tilney
R Loertscher
P304
P356
10.7326/0003-4819-101-5-667
P407
P577
1984-11-01T00:00:00Z